- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kathy Oubre on Challenges, Solutions to Addressing Clinical Trial Participation
The clinicians and nurses at Pontchartrain Cancer Center address the education behind the clinical trials, which helps patients understand that they can have access to cutting edge therapy that they would not otherwise have access to, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020.
"Our clinicians and our nurses address the education behind the clinical trials, the ability to, in a lot of cases, have access to cutting edge therapy that they would not otherwise have access to," said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020 and can be registered for here.
Transcript
Pontchartrain Cancer Center is located in southeastern Louisiana; what challenges do you face when providing care to patients in this area?
So, you have to first get past the stigma of the patient feeling like a test subject. I think that was very common 10 or 20 years ago. I think clinical trials got a bad reputation from that. We primarily address that through education. Our clinicians and our nurses just address the education behind the clinical trials, the ability to, in a lot of cases, have access to cutting edge therapy that they would not otherwise have access to. Educating them about all of the advances in science and how they might be able to have that hand in changing therapy for themselves and other people coming after them.
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH
June 20th 2025The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most vulnerable, explains Colleen Kelley, MD, MPH, Rollins School of Public Health at Emory University.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
